Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
10.1016/j.bbagen.2018.05.018 Biochim Biophys Acta General Sub
It upregulates vascular endothelial growth factor (VEGF) and its receptor VEGFR2, directly promoting angiogenesis the formation of new blood vessels at injury sites
Important: Microdosing is not a self-selected plan
While the clinical significance of this in healthy adults is still being characterised, the theoretical concern about sustained supraphysiological IGF-1 and long-term tissue effects is the basis for the oncogenic risk concerns flagged in the long-term safety literature
Side Effects and Safety Comparison# BPC-157 Side Effects# Animal studies report no significant adverse effects at standard research doses
Download GLP Trackr on the App Store or Google Play and start your free 7-day trial today
US$ 24.24
US$ 29.46
US$ 20.93
US$ 28.29
US$ 22.14
US$ 20.48
US$ 24.48
US$ 21.66
US$ 28.37
US$ 22.95
US$ 21.00
US$ 20.69
US$ 20.32
US$ 26.31
